CARMA FUND
Munich, Bavariacarma-fund.com
Overview
CARMA FUND I is an early-stage investment fund for advancing Life Science and Healthcare technologies. The fund started off with a First Closing in June 2022 and has €50M under management. It is based in Munich and Frankfurt am Main. The fund invests in opportunities from the Life Science and Healthcare sector, including R&D tools, platform technologies, improvements to the healthcare system or technologies from the white or green biotech sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kupando | Mar 2026 | Series A Extension | Co-investor |
| Exciva GmbH | Jan 2026 | Series B | Co-investor |
| TECregen | Jan 2026 | Seed | Co-investor |
| WMT AG | Oct 2025 | VC Round | Co-investor |
| Elkedonia | Jun 2025 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
